Yes, several are in the final stages of development
Multiomics study of nonalcoholic fatty liver disease
In health, Judy
The anabolic variety and redox status of GSH in the myocardium under pathological conditions When the heart is under stress from pathological factors, GSH redox homeostasis is disrupted, which is manifested by a significant decrease in GSH content and accumulation of GSSG in the myocardium
[11] [12] When combined, these effects could be additive, potentially increasing the risk of hypoglycaemia, particularly in vulnerable individuals
Uses: Primary systemic carnitine deficiency Acute and chronic treatment of inborn errors of metabolism resulting in secondary carnitine deficiency Prevention and treatment of carnitine deficiency in end stage renal disease patients undergoing dialysis (IV form only) Usual Pediatric Dose for Carnitine Deficiency METABOLIC DISORDERS: Oral solution or tablets: Initial dose: 50 mg/kg/day orally in evenly divided doses Maintenance dose: 50 to 100 mg/kg/day orally in evenly divided doses Maximum dose: 3 grams per day Intravenous solution: 50 mg/kg as a slow 2 to 3 minute bolus or by infusion, once a day A loading dose may be given in severe metabolic crisis, followed by an equivalent dose every 3 to 4 hours (but not less often than every 6 hours) over the following 24 hours Subsequent daily doses should be in the range of 50 mg/kg or as therapy may require The highest dose administered has been 300 mg/kg
